Locations
Cambridge, UK · Streetly End, Cambridge CB21 4RP, UK
industry
Biotechnology · Data and Analytics · DeepTech · Health · Software
Size
11-50 employees
Stage
Seed
founded in
2017
Shift Bioscience is pioneering simulation-guided cell rejuvenation to combat aging-related diseases. The company has developed a high-throughput, high-accuracy aging biomarker and an AI platform that identifies safer rejuvenation gene-factors. Their innovative approach allows for the screening of thousands of molecules and cocktails to discover first-in-class therapeutics. With a talented team of researchers and strong backing from biotech investors, Shift aims to create a drug-family that can address multiple aging diseases, positioning itself as a leader in the longevity biotech space.
Something looks off?